Helicobacter pylori-induced downregulation of the secretory leukocyte protease inhibitor (SLPI) in gastric epithelial cell lines and its functional relevance for H. pylori-mediated diseases

Biological Chemistry

Volumn 387, Issue 7, 2006, Pages 893-901

  Wex, Thomas ^a   Treiber, Gerhard ^a   Venerito, Marino ^a   Leodolter, Andreas ^a   Peitz, Ulrich ^a   Kuester, Doerthe ^a   Hritz, Istvan ^a,b   Krueger, Sabine ^a   Roessner, Albert ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Elastase; Gastric cell lines; H. pylori infection; Serine proteases; SLPI

Indexed keywords

LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

CELL LINE; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; HELICOBACTER PYLORI; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STOMACH EPITHELIUM; STOMACH MUCOSA; STOMACH TUMOR; UPREGULATION;

BASE SEQUENCE; CELL LINE; DNA PRIMERS; DOWN-REGULATION; EPITHELIAL CELLS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; STOMACH; STOMACH NEOPLASMS;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 33746255615     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.113     Document Type: Conference Paper

References (52)

1. Abe, T., Kobayashi, N., Yoshimura, K., Trapnell, B.C., Kim, H., Hubbard, R.C., Brewer, M.T., Thompson, R.C., and Crystal R.G. (1991). Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J. Clin. Invest. 87, 2207-2215.
2. Alkemade, J.A., Molhuizen, H.O., Ponec, M., Kempenaar, J.A., Zeeuwen, P.L., de Jongh, G.J., van Vlijmen-Willems, I.M., van Erp, P.E., Van de Kerkhof, P.C., and Schalkwijk, J. (1994). SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J. Cell Sci. 107, 2335-2342.
3. Ashcroft, G.S., Lei, K., Jin, W., Longenecker, G., Kulkarni, A.B., and Greenwell-Wild, T. (2000). Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6, 1147-1153.
4. Bergenfeldt, M., Nystrom, M., Bohe, M., Lindstrom, C., Polling, A., and Ohlsson, K. (1996). Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa. J. Gastroenterol. 31, 18-23.
5. Boudier, C., Cadene, M., and Bieth, J.G. (1999). Inhibition of neutrophil cathepsin G by oxidized mucus proteinase inhibitor. Effect of heparin. Biochemistry 38, 8451-8457.
6. Brandt, S., Kwok, T., Hartig, R., Konig, W., and Backert, S. (2005). NF-κ activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. USA 102, 9300-9305.
7. Buhling, F., Peitz, U., Kruger, S., Kuster, D., Vieth, M., Gebert, I., Roessner, A., Weber, E., Malfertheiner, P., and Wex, T. (2004). Cathepsins K, L, B, X and W are differentially expressed in normal and chronically inflamed gastric mucosa. Biol. Chem. 385, 439-445.
8. Chattopadhyay, A., Gray, L.R., Patton, L.L., Caplan, D.J., Slade, G.D., Tien, H.C., and Shugars, D.C. (2004). Salivary secretory leukocyte protease inhibitor and oral candidiasis in human immunodeficiency virus type 1-infected persons. Infect. Immun. 72, 1956-1963.
9. Crabtree, J.E. (1996). Immune and inflammatory responses to Helicobacter pylori infection. Scand. J. Gastroenterol. (Suppl.) 215, 3-10.
10. Dixon, M.F., Genta, R.M., Yardley, J.H., and Correa, P. (1996). Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol. 20, 1161-1181.
11. Dohchin, A., Suzuki, J.I., Seki, H., Masutani, M., Shiroto, H., and Kawakami Y. (2000). Immunostained cathepsins B and L correlate with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 89, 482-487.
12. Duits, L.A., Tjabringa, G.S., Aarts, N.J., van't Wout, J.W., Hiemstra, P.S., Nibbering, P.H., and van Dissel, J.T. (2003). Plasma secretory leukocyte protease inhibitor in febrile patients. Clin. Microbiol. Infect. 9, 605-613.
13. Figueiredo, C., Machado, J.C., and Yamaoka, Y. (2005). Pathogenesis of Helicobacter pylori infection. Helicobacter 10 (Suppl. 1), 14-20.
14. Fink, E., Nettelbeck, R., and Fritz, H. (1986). Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors. Biol. Chem. Hoppe-Seyler 367, 567-571.
15. Fritz, H. (1988). Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI). Biol. Chem. Hoppe-Seyler 369, 79-82.
16. Gils, A. and Declerck, P.J. (1998). Structure-function relationships in serpins: current concepts and controversies. Thromb. Haemost. 80, 531-541.
17. Grobmyer, S.R., Barie, P.S., Nathan, C.F., Fuortes, M., Lin, E., Lowry, S.F., Wright, C.D., Weyant, M.J., Hydo, L., Reeves, F., Shiloh, M.U., and Ding, A. (2000). Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit. Care Med. 28, 1276-1282.
18. Heinzel, R., Appelhans, H., Gassen, G., Seemuller, U., Machleidt, W., Fritz, H., and Steffens, G. (1986). Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. Eur. J. Biochem. 160, 61-67.
19. Henriksen, P.A., Hitt, M., Xing, Z., Wang, J., Haslett, C., Riemersma, R.A., Webb, D.J., Kotelevtsev, Y.V., and Sallenave, J.M. (2004). Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-κB-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J. Immunol. 172, 4535-4544.
20. Hiemstra, P.S., Maassen, R.J., Stolk, J., Heinzel-Wieland, R., Steffens, G.J., and Dijkman, J.H. (1996). Antibacterial activity of antileukoprotease. Infect. Immun. 64, 4520-4524.
21. Hritz, I., Kuester, D., Vieth, M., Herszenyi, L., Stolte, M., Roessner, A., Tulassay, Z., Wex, T., and Malfertheiner, P. (2006). Secretory leukocyte protease inhibitor expression in various types of gastritis: a specific role of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 18, 277-282.
22. Itoh, T., Wakatsuki, Y., Yoshida, M., Usui, T., Matsunaga, Y., Kaneko, S., Chiba, T., and Kita, T. (1999). The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J. Gastroenterol. 34, 560-570.
23. Jones, B.D. (2005). Salmonella invasion gene regulation: a story of environmental awareness. J. Microbiol. 43, 110-117.
24. Koyama, S. (2004). Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis. Scand. J. Gastroenterol. 39, 1046-1053.
25. Lentsch, A.B., Jordan, J.A., Czermak, B.J., Diehl, K.M., Younkin, E.M., Sarma, V., and Ward, P.A. (1999). Inhibition of NF-kappa;B activation and augmentation of IκBβ by secretory leukocyte protease inhibitor during lung inflammation. Am. J. Pathol. 154, 239-247.
26. Lindholm, C., Quiding-Jarbrink, M., Lonroth, H., and Svennerholm, A.M. (2001). Induction of chemokine and cytokine responses by Helicobacter pylori in human stomach explants. Scand. J. Gastroenterol. 36, 1022-1029.
27. Naumann, M. (2001). Host cell signaling in Helicobacter pylori infection. Int. J. Med. Microbiol. 291, 299-305.
28. Parsonnet, J., Friedman, G.D., Vandersteen, D.P., Chang, Y., Vogelman, J.H., Orentreich, N., and Sibley, R.K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131.
29. Potempa, J., Korzus, E., and Travis, J. (1994). The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269, 15957-15960.
30. + T cell responses in Helicobacter pylori-infected individuals. Clin. Exp. Immunol. 123, 81-87.
31. Sallenave, J.M. (2000). The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir. Res. 1, 87-92.
32. Singh, P.K., Tack, B.F., McCray, P.B. Jr., and Welsh, M.J. (2000) Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, 799-805.
33. Si-Tahar, M., Merlin, D., Sitaraman, S., and Madara, J.L. (2000). Constitutive and regulated secretion of secretory leukocyte proteinase inhibitor by human intestinal epithelial cells. Gastroenterology 118, 1061-1071.
34. Song, X., Zeng, L., Jin, W., Thompson, J., Mizel, D.E., Lei, K., Billinghurst, R.C., Poole, A.R., and Wahl, S.M. (1999). Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 190, 535-542.
35. Suerbaum, S. and Michetti, P. (2002). Helicobacter pylori infection. N. Engl. J. Med. 347, 1175-1186.
36. Taggart, C.C., Lowe, G.J., Greene, C.M., Mulgrew, A.T., O'Neill, S.J., Levine, R.L., and McElvaney, N.G. (2000). Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor. J. Biol. Chem. 276, 33345-33352.
37. Taggart, C.C., Greene, C.M., McElvaney, N.G., and O'Neill, S. (2002). Secretory leucoprotease inhibitor prevents LPS-induced IκBβ degradation without affecting phosphorylation or ubiquitination. J. Biol. Chem. 277, 33648-33653.
38. Tam, E.M., Morrison, C.J., Wu, Y.I., Stack, M.S., and Overall, C.M. (2004). Membrane protease proteomics: isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates. Proc. Natl. Acad. Sci. USA 101, 6917-6922.
39. Thompson, R.C. and Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 83, 6692-6696.
40. Toh, B.H., van Driel, I.R., and Gleeson, P.A. (1997). Pernicious anemia. N. Engl. J. Med. 337, 1441-1448.
41. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R.J. (2001). Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789.
42. Wang, X., Li, X., Xu, L., Zhan, Y., Yaish-Ohad, S., Erhardt, J.A., Barone, F.C., and Feuerstein, G.Z. (2003). Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol. Pharmacol. 64, 833-840.
43. Wex, T., Treiber, G., Lendeckel, U., and Malfertheiner, P. (2003). A two step method for the extraction of high-quality RNA from endoscopic biopsies. Clin. Chem. Lab. Med. 41, 1033-1037.
44. Wex, T., Treiber, G., Nilius, M., Vieth, M., Roessner, A., and Malfertheiner, P. (2004a). Helicobacter pylori-mediated gastritis induces local downregulation of secretory leukocyte protease inhibitor in the antrum. Infect. Immun. 72, 2383-2385.
45. Wex, T., Sokic-Milutinovic, A., Todorovic, V., Bjelovic, M., Milosavljevic, T., Pesko, P., and Malfertheiner, P. (2004b). Downregulation of secretory leukocyte protease inhibitor expression in gastric mucosa is a general phenomenon in Helicobacter pylori-related gastroduodenal diseases. Dig. Dis. 22, 390-395.
46. Wex, T., Zack, M., and Malfertheiner, P. (2006a). Proteases in Helicobacter pylori-mediated diseases. In: Proteases in Biology and Disease, Volume 5: Proteases in Gastrointestinal Tissues, U. Lendeckel and N.M. Hooper, eds. (New York, USA: Springer Science/Business Media Inc.), pp. 61-87.
47. Wex, T., Ye, S., Treiber, G., Vieth, M., Roessner, A., and Malfertheiner, P. (2006b). H. pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor (SLPI) in gastroduodenal mucosa. Helicobacter 11, 31-38.
48. Wiedow, O. and Meyer-Hoffert, U. (2005). Neutrophil serine proteases: potential key regulators of cell signaling during inflammation. J. Intern. Med. 257, 319-328.
49. Yang, J., Zhu, J., Sun, D., and Ding, A. (2005). Suppression of macrophage responses to bacterial lipopolysaccharide (LPS) by secretory leukocyte protease inhibitor (SLPI) is independent of its anti-protease function. Biochim. Biophys. Acta 1745, 310-317.
50. Zhang, D., Simmen, R.C., Michel, F.J., Zhao, G., Vale-Cruz, D., and Simmen, F.A. (2002). Secretory leukocyte protease inhibitor mediates proliferation of human endometrial epithelial cells by positive and negative regulation of growth-associated genes. J. Biol. Chem. 277, 29999-30009.
51. Zarrilli, R., Ricci, V., and Romano, M. (1999). Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Microbiol. 1, 93-99.
52. Zhu, J., Nathan, C., Jin, W., Sim, D., Ashcroft, G.S., Wahl, S.M., Lacomis, L., Erdjument-Bromage, H., Tempst, P., Wright, C.D., and Ding, A. (2002). Conversion of proepithelin to epithelia: roles of SLPI and elastase in host defense and wound repair. Cell 111, 867-878.